These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15633347)

  • 1. [The double messages about atenolol must be an issue for the SBU board].
    Werkö L; Enkvist C
    Lakartidningen; 2004 Dec; 101(49):4038, 4041; discussion 4041-2, 4045. PubMed ID: 15633347
    [No Abstract]   [Full Text] [Related]  

  • 2. [An article in Lancet set a SBU report rocking. When SBU authors question their own conclusions: Who is to be trusted?].
    Rosengren A
    Lakartidningen; 2005 Feb 28-Mar 6; 102(9):617-8. PubMed ID: 15804033
    [No Abstract]   [Full Text] [Related]  

  • 3. [Errors about SBU statement and atenolol].
    Rehnqvist N
    Lakartidningen; 2005 Feb 14-20; 102(7):503. PubMed ID: 15768702
    [No Abstract]   [Full Text] [Related]  

  • 4. [Criticism against the atenolol meta-analysis remains].
    Forsén K
    Lakartidningen; 2005 Feb 7-13; 102(6):412, 414; discussion 414-5. PubMed ID: 15754686
    [No Abstract]   [Full Text] [Related]  

  • 5. [Noticeable meta-analysis of atenolol does not cover all aspects].
    Forsén K
    Lakartidningen; 2005 Jan 3-16; 102(1-2):61-3. PubMed ID: 15707110
    [No Abstract]   [Full Text] [Related]  

  • 6. Atenolol and cardiovascular risk: an issue close to the heart.
    Wilkinson IB; McEniery CM; Cockcroft JR
    Lancet; 2006 Feb; 367(9511):627-9. PubMed ID: 16503444
    [No Abstract]   [Full Text] [Related]  

  • 7. Atenolol versus other beta-adrenergic blockers.
    Aursnes I; Osnes JB
    J Am Coll Cardiol; 2009 Jun; 53(22):2101-2; author reply 2106-7. PubMed ID: 19477363
    [No Abstract]   [Full Text] [Related]  

  • 8. [Atenolol or metoprolol as beta-blocker in the treatment of hypertension].
    van den Born BJ; Brewster LM; Koopmans RP; van Montfrans GA
    Ned Tijdschr Geneeskd; 2005 Aug; 149(32):1808-9. PubMed ID: 16121668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treating essential hypertension. Are beta blockers still first choice?].
    Rahn KH
    MMW Fortschr Med; 2007 May; 149(18):43-5. PubMed ID: 17672414
    [No Abstract]   [Full Text] [Related]  

  • 10. Atenolol is dead: long live beta-blockade.
    Cockcroft JR
    J Am Coll Cardiol; 2009 Jun; 53(22):2102; author reply 2106-7. PubMed ID: 19477365
    [No Abstract]   [Full Text] [Related]  

  • 11. Beta-blockers should remain as first-line therapy in the management of hypertension.
    Krum H
    Int J Clin Pract; 2008 Aug; 62(8):1137-41. PubMed ID: 18705818
    [No Abstract]   [Full Text] [Related]  

  • 12. [Atenolol or metoprolol as beta-blocker in the treatment of hypertension].
    Wiersma T; Verduijn M; Bouma M; Goudswaard AN
    Ned Tijdschr Geneeskd; 2005 Oct; 149(44):2482; author reply 2482-3. PubMed ID: 16285368
    [No Abstract]   [Full Text] [Related]  

  • 13. The LIFE Trial in 2004.
    Beevers DG
    J Hum Hypertens; 2004 Jun; 18(6):365. PubMed ID: 15153931
    [No Abstract]   [Full Text] [Related]  

  • 14. [Does Kent Forsen possibly have a complete picture about atenolol?].
    Carlberg B; Samuelsson O; Lindholm LH
    Lakartidningen; 2005 Jan 17-23; 102(3):151-2. PubMed ID: 15712744
    [No Abstract]   [Full Text] [Related]  

  • 15. Guidelines on high blood pressure in pregnancy give new classifications of disease.
    Rollins G
    Rep Med Guidel Outcomes Res; 2000 Dec; 11(24):5-7. PubMed ID: 11902247
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cardiac protection of atenolol: want of proof].
    Shi ZW
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(13):928-30. PubMed ID: 16029536
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug committees welcome the SBU hypertension report. A number of patients can be offered cost-effective, evidence-based therapy].
    Ohlsson O
    Lakartidningen; 2004 Dec; 101(49):3984-5. PubMed ID: 15633336
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of losartan compared with atenolol on the incidence of revascularization in patients with hypertension and electrocardiographic left ventricular hypertrophy. The LIFE study.
    Olsen MH; Wachtell K; Dahlöf B; Devereux RB; Ibsen H; Kjeldsen SE; Lindholm LH; Lyle PA; Nieminen MS
    J Hum Hypertens; 2006 Jun; 20(6):460-4. PubMed ID: 16572193
    [No Abstract]   [Full Text] [Related]  

  • 19. Newly diagnosed hypertension and depressive symptoms: how would you treat?
    Huffman JC; Wulsin LR; Stern TA
    J Fam Pract; 2005 Jan; 54(1):39-46. PubMed ID: 15623406
    [No Abstract]   [Full Text] [Related]  

  • 20. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
    Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.